Abstract
Studies of natural rotavirus (RV) infection in children have shown that protection against subsequent RV disease occurs (1). Assessment of humoral immune responses has included study of the importance of circulating vs intestinal antibodies (Abs), serotype-specific vs group-specific Abs, and RV-specific immunoglobulins IgA, IgM, and IgG (1). Following natural RV infection, RV-specific IgM, followed by IgA and IgG, appear in serum and duodenal fluid or stool of young children (2). Protection against subsequent RV infection is predicted by the quantity of virus-specific IgA in the feces and serum (3, 4). In addition, virus-specific antibody-secreting cells (ASC) of the IgA, IgM, and IgG isotypes have been detected in the blood of infants following RV infection (5), although correlation between the presence of ASCs and protection against subsequent disease has not been studied. Serum neutralizing antibodies (nAbs) occur after natural RV infection in children, and are serotype-specific (4,6). Overall, protection against subsequent RV infection is correlated with higher titers of nAb (4). Protection against infection has been correlated with homotypic nAb to the G1 serotype (4); however, other studies suggest that protection is not dependent on serotype-specific nAb (7).
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Offit, P. A. (1994) Immunologic determinants of protection against rotavirus disease. Curr. Top. Microbiol. and Immun. 85, 229–254.
Davidson, G. P., Hogg, R. J., and Kirubakaran, C. P. (1983) Serum and intestinal response to rotavirus enteritis in children. Infect. Immun. 40, 447–452.
Coulson, B., Grimwood, K., Hudson, I., Barnes, G., and Bishop, R. (1992) Role of coproantibody in clinical protection of children during reinfection with rotavirus. J. Clin. Microbiol. 30,1678–1684.
O’Ryan, M. L., Matson, D. O., Estes, M. K., and Pickering, L. K. (1994) Anti-rotavirus G-type specific and isotype-specific antibodies in children with natural rotavirus infection. J. Infect. Dis. 169, 504–511.
Kaila, M., Isolauri, E., Soppi, E., Virtanen, E., Laine, S., and Arvilommi, H. (1992) Enhancement of the circulating antibody secreting cell response in human diarrhea by a human lactobacillus strain. Ped. Res. 32, 141–144.
Coulson, B. S., Fowler, K. J., Bishop, R. F., and Cotton, R. G. H. (1985) Neutralizing monoclonal antibodies to human rotavirus and indications of antigenic drift among strains from neonates. J. Virol. 54, 14–20
Ward, R. L., Clemens, J. D., Knowlton, D. R., Rao, M. R., Van Loon, F. P. L., Huda, N., Ahmed, F., Schiff, A. M., and Sack, D. A. (1992) Evidence that protection against rotavirus diarrhea after natural infection is not dependent on serotype-specific neutralizing antibody. J. Infect. Dis. 166, 1251–1257.
Totterdell, B. M., Patel, S., Banatvala, J. E., and Chrystie, I. L. (1988) Development of a lymphocyte transformation assay for rotavirus in whole blood and breast milk. J. Med. Virol. 25, 27–36
Offit, P. A., Hoffenberg, E. J., Pia, E. S., Panackal, P. A., and Hill, N.L. (1992) Rotavirus-specific helper T cell responses in newborns, infants, children and adults. J. Infect. Dis. 165, 1107–1111.
Ward, R. and Bernstein, D. (1995) Lack of correlation between serum rotavirus antibody titers and protection following vaccination with reassortant RRV vaccines. Vaccine 13, 1226–1232.
Ward, R. L., Knowlton, D. R., Zito, E. T., Davidson, B. L., Rappaport, R., and Mack, M. E. (1997) Serologic correlates of immunity in a tetravalent reassortant rotavirus vaccine trial. J. Infect. Dis. 176, 570–577.
Isolauri, E., Joensuu, J., Suomalainen, H., Loumala, M., and Vesikari, T. (1995) Improved immunogenicity of oral D × RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine 13, 310–312.
Khoury, C. A, Brown, K. A., Kim, J. E., and Offit, P. A. (1994) Rotavirus-specific intestinal immune response in mice assessed by enzyme-linked immunospot assay and intestinal fragment culture. Clin. Diag. Lab. Immunol. 1, 772–728.
Chen, W. K., Campbell, T., vanCott, J., and Saif, L. J. (1995) Enumeration of isotype-specific antibody-secreting cells derived from gnotobiotic piglets inoculated with porcine rotaviruses. Vet. Immunol. Immunopath. 45, 265–284.
Bridger, J. C. and Oldham, G. (1987) Avirulent rotavirus infections protect calves from disease with and without inducing high levels of neutralizing antibody. J. Gen. Virol. 68, 2311–2317.
Offit, P. A. and Dudzik, K. I. (1990) Rotavirus-specific cytotoxic T lymphocytes passively protect against gastroenteritis in suckling mice. J. Virol. 64, 6325–6328.
Dharakul, T., Rott, L., and Greenberg, H. B. (1990) Recovery from chronic rotavirus infection in mice with severe combined immunodeficiency: virus clearance mediated by adoptive transfer of immune CD8+ T lymphocytes. J. Virol. 64, 4375–4382.
Yolken, R. H., Wyatt, R. G., Kim, H. W., Kapikian, A. Z., and Chanock, R. M. (1978) Immunologic response to infection with human reovirus-like agent: measurement of anti-human reovirus-like agent immunoglobulin G and M levels by the method of enzyme-linked immunosorbant assay. Infect. Immun. 19, 540–546.
Babiuk, L. A., Acres, S. D., and Rouse, B. T. (1977) Solid-phase radioim-munoassay for detecting bovine (neonatal calf diarrhea) rotavirus antibody. J. Clin. Microbiol. 6, 10–15.
Gust, I. D., Pringle, R. C., Barnes, G. L., Davidson, G. P., and Bishop, R. F. (1977) Complement fixing antibody response to rotavirus infection. J. Clin. Microbiol. 5, 125–130.
Matsuno, S., Inouye, S., Hasegawa, A., and Kono, R. (1982) Assay of human rotavirus antibody by immune adherence hemagglutination with a cultivable human rotavirus as antigen. J. Clin. Microbiol. 15, 163–165.
Martin, M. L., Gary, G. W. Jr., and Palmer, E. L. (1979) Comparison of hemagglutination-inhibition, complement-fixation and enzyme-linked immunosorbant assay for quantitation of human rotavirus antibodies. Arch. Virol. 62, 131–136.
Matsuno, S., Inouye, S., and Kono, R. (1977) Plaque assay of neonatal calf diarrhea virus and the neutralizing antibody in human sera. J. Clin. Microbiol. 5, 1–4.
Knowlton, D. R., Spector, D. M., and Ward, R. L. (1991) Development of an improved method for measuring neutralizing antibody to rotavirus. J. Virol. Methods 33, 127–134.
Shaw, R. D., Fong, K. J., Losonsky, G. A., Levine, M., Maldonado, Y., Yolken, R., Tilores, J., Kapikian, A. Z., Vo., P. T., and Greenberg, H. B. (1987) Epitope-spe-cific immune responses to rotavirus vaccination. Gastroenterology 93, 941–950.
Offit, P. A., Clark, H. F., and Plotkin, S. A. (1984) Response of mice to rotaviruses of bovine or primate origin assessed by radioimmunoassay, radioimmunoprecipitation, and plaque-reduction neutralization. Infect. Immun. 42, 293–300.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2000 Humana Press Inc., Totowa, NJ
About this protocol
Cite this protocol
Macartney, K.K., Offit, P.A. (2000). Immunologic Methods and Correlates of Protection. In: Gray, J., Desselberger, U. (eds) Rotaviruses. Methods in Molecular Medicine™, vol 34. Humana Press. https://doi.org/10.1385/1-59259-078-0:119
Download citation
DOI: https://doi.org/10.1385/1-59259-078-0:119
Publisher Name: Humana Press
Print ISBN: 978-0-89603-736-6
Online ISBN: 978-1-59259-078-0
eBook Packages: Springer Protocols